Stemcell United Limited Share Price Australian S.E.
Equities
BP8
AU000000SCU9
Biotechnology & Medical Research
Sales 2022 | 14.35M 9.43M 750M | Sales 2023 | 339 222.65 17.72K | Capitalization | 3.85M 2.53M 202M |
---|---|---|---|---|---|
Net income 2022 | -3M -1.97M -157M | Net income 2023 | -4M -2.63M -209M | EV / Sales 2022 | 1.07 x |
Net Debt 2022 | 627K 412K 32.77M | Net cash position 2023 | 511K 336K 26.72M | EV / Sales 2023 | 9,862 x |
P/E ratio 2022 |
-3.98
x | P/E ratio 2023 |
-0.72
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.24% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Leonard
CEO | Chief Executive Officer | 53 | 29/03/23 |
Justyn Stedwell
SEC | Corporate Secretary | - | 04-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 20/07/21 | |
Paul Stephenson
CHM | Chairman | 63 | 30/03/20 |
Yan Hua Huang
BRD | Director/Board Member | - | 26/05/19 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |